A minireview: Role of AMP-activated protein kinase (AMPK) signaling in obesity-related renal injury
Authors:
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 265, 118828
Abstract
No abstract availableKeywords
Funding Information
- Jilin Province (2019SRCJ015)
This publication has 98 references indexed in Scilit:
- Keap1 degradation by autophagy for the maintenance of redox homeostasisProceedings of the National Academy of Sciences, 2012
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial FunctionCell Metabolism, 2012
- SIRT3 Deficiency and Mitochondrial Protein Hyperacetylation Accelerate the Development of the Metabolic SyndromeMolecular Cell, 2011
- Regulation of Hepatic Lipin-1 by Ethanol: Role of AMP-Activated Protein Kinase/Sterol Regulatory Element-Binding Protein 1 Signaling in MiceHepatology, 2011
- Effect of the HMG-CoA Reductase Inhibitor Rosuvastatin on Early Chronic Kidney Injury in Obese Zucker Rats Fed With an Atherogenic DietThe American Journal of the Medical Sciences, 2009
- PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid storesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Regulation of Rac1 by Simvastatin in Endothelial CellsJournal of Biological Chemistry, 2009
- Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1–phosphatidylinositol-3-kinase complexNature Cell Biology, 2009
- Insulin Resistance, Oxidative Stress, and Podocyte Injury: Role of Rosuvastatin Modulation of Filtration Barrier InjuryAmerican Journal of Nephrology, 2007
- Functions of AMP‐activated protein kinase in adipose tissueThe Journal of Physiology, 2006